Johns Hopkins Medicine: Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers
November 16, 2024
November 16, 2024
BALTIMORE, Maryland, Nov. 16 (TNSres) -- Johns Hopkins Medicine issued the following news release:
A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center and Oregon Health & Science University.
The immune microenvironment around a pancreatic tumor has suppressed immune activity, allowing the tumor to e . . .
A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center and Oregon Health & Science University.
The immune microenvironment around a pancreatic tumor has suppressed immune activity, allowing the tumor to e . . .